EPIX Pharmaceuticals, Inc. Announces August 25, 2009 for the Auction Sale of Equipment and September 30, 2009 for the Auction Sale of the Intellectual Property

...t diseases of the central nervous system and lung conditions. In addition, epix has programs related to its MRI imaging business. epix also has collaborations with several leading pharmaceutical and research fo...

EPIX Pharmaceuticals, Inc. Assigns all Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors

...., C.P.A. ("Finn"), announced today that assets of epix Pharmaceuticals, Inc. ("EPIX") have been assigned ... nervous system and lung conditions. In addition, epix has several programs related to its MRI imaging bu...adofosveset trisodium, by Bayer Schering Pharma.) epix also has collaborations with several leading pharm...

New Immune Approach for Treatment of Alzheimer's Disease

...ress in Philadelphia on June 10 and 11. On the second day of this conference, after presentations by researchers from Abbott Laboratories, Medivation, epix Pharmaceuticals, the Buck Institute, Cleveland Clinic, and others, Edward Tobinick MD, Director of the Institute for Neurological Research® (INR&...

EPIX in Medical Technology

EPIX Pharmaceuticals Announces Statistically Significant Results in Cognitive Function from Phase 1b Clinical Trial of Novel 5-HT6 Drug Candidate

...tor (GPCR) known as 5-HT6, which was discovered by epix using its proprietary in silico drug discovery pla...reaction time; and information processing. About epix epix Pharmaceuticals is a biopharmaceutical company foc...

EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3 Clinical Trial at 47th Annual NCDEU Meeting

... in the first half of next year." In March 2007, epix announced the initiation of a randomized, double-b... subject of a composition of matter patent held by epix which extends through 2024. About epix ...

EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

...ed on the company's website for two weeks. About epix epix Pharmaceuticals is a biopharmaceutical company foc...) approved in 32 countries and marketed in Europe. epix also has collaborations with leading organizations...

EPIX in Biological Technology

Biotech Hot in July Driven by Positive Drug Data and Acquisitions

...f and/or putting promising projects in the refrigerator. Recent announcements included: - Celera cut 80 employees or 13 percent of its workforce - epix Pharmaceuticals entered bankruptcy and is winding down its operations. - YTD the Burrill Biotech Select Index is up 4 percent ...

2009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60% Despite Current Recession

...el Pharma, Anacor Pharmaceuticals, Ceragenix, Millennium Pharmaceuticals (Takeda), Pharmasset, Oscient Pharmaceuticals, Cenomed Biosciences, Alkermes, epix Pharmaceuticals, and Ardea Biosciences. The exhibit area is strictly limited to 100 booths and is nearly full 3 1/2 months before the show. The...

Proteolix Announces New Appointment in Finance and Expands Clinical and Regulatory Leadership Team

...uding PR-047, an oral proteasome inhibitor for the treatment of cancer. Most recently, Dr. Kauffman was President and Chief Executive Officer of epix Pharmaceuticals, Inc. (previously Predix Pharmaceuticals, Inc.) from 2002 to 2008. From 1997 to 2002, he held a number of senior medical and program ...

Gene Network Sciences Announces Michael Gilman as Board Member

...sity of California, Berkeley , and an S.B. in Life Sciences from Massachusetts Institute of Technology . He also serves on the Board of Directors of epix Pharmaceuticals, Inc. "Michael Gilman's broad pharma research leadership experience will play a critical role in GNS's effectively deploying our ...

Biotechnology Veteran Michael Webb Joins Boston-based Investment Bank as Senior Advisor

...nce and depth of sector knowledge will be of tremendous value to both the firm and its clients." Mr. Webb was previously President & CEO of epix Pharmaceuticals where he completed over $225 million in financings, including its 1997 IPO, and raised an additional $150 million through corporate pa...

Proteon Therapeutics Appoints Experienced Biopharmaceutical Executive, Gregory D. Phelps to its Board of Directors

...zyme Corporation and Vice President of Baxter Travenol Laboratories, Inc (now Baxter Healthcare). Mr. Phelps is currently on the Board of Directors of epix Pharmaceuticals and has previously served on the Boards of Directors of nine public and private companies in the health care field, as well as on the ...

BioVascular, Inc. Expands Executive Team

...o Eli Lilly for $315M; Novacardia, sold to Merck for $350M; Predix, sold to epix Medical; and Adiana, sold to Cytyc. Prior to working at Forward Ventures, M...pinski held business development and strategic planning roles at Genentech, epix Medical and the pharmaceutical consulting practice of Arthur D. Little. Mr....

New Report Analyzes Key Controversies in Multiple Sclerosis Treatment

...MAb. Drugs/Mechanisms mentioned in this report include: S1P agonists (fingolimod; Novartis, S1P1; Roche/Actelion, Sphingomab; Lpath, S1P1 modulators; epix / Amgen), inhibitors of DNA synthesis/repair (teriflunomide; Sanofi-Aventis, cladribine; Ivax/Serono), potassium channel blockers (fampridine; Acorda,...